IntraLase Corp. Offers Free Access To Laser Corneal Transplantation For Patients Suffering From Vision Loss Due To Fusarium Keratitis

IntraLase Corp. (Nasdaq:ILSE) announced today that patients requiring corneal transplant surgery resulting from the recent outbreak of Fusarium keratitis eye infection can take advantage of the benefits of corneal transplantation with the advanced IntraLase(R) FS Laser free of charge.